| John Scott Butterfield, PD | |
|
2135 N West Ave, El Dorado, AR 71730-3351 | |
| (870) 862-5458 | |
| (870) 862-0076 |
| Full Name | John Scott Butterfield |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2135 N West Ave, El Dorado, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154604247 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD07127 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Scott Butterfield, PD 2135 N West Ave, El Dorado, AR 71730-3351 Ph: (870) 862-5458 | John Scott Butterfield, PD 2135 N West Ave, El Dorado, AR 71730-3351 Ph: (870) 862-5458 |
News Archive
PBS' NewsHour's "The Rundown" blog examines the recent naming of eight countries to receive additional technical and management resources under President Barack Obama's Global Health Initiative (GHI).
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
Queensland health are in a spot of bother yet again over the employment of a foreign born doctor.
› Verified 6 days ago
Mrs. Joy L Bowen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 347 W Oak St, El Dorado, AR 71730 Phone: 870-862-4931 Fax: 870-862-6659 | |
Harold Otwell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 429 Williams Rd, El Dorado, AR 71730 Phone: 870-310-0098 | |
Lindsey Ables, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 715 N College Ave Ste P1, El Dorado, AR 71730 Phone: 870-639-6227 Fax: 870-639-6058 | |
Jameson Obidinma Ihuefo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2730 N West Ave, El Dorado, AR 71730 Phone: 870-862-2128 | |
Mrs. Casey N Deyampert, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 347 W Oak St, El Dorado, AR 71730 Phone: 870-862-4931 Fax: 870-862-6659 | |
Wendy D Bain, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2135 N West Ave, El Dorado, AR 71730 Phone: 870-862-5458 Fax: 870-862-0076 |